Literature DB >> 35048213

Overview of signal transduction between LL37 and bone marrow-derived MSCs.

Yingkang Zhu1, Faitai Lu1, Guodong Zhang1, Zunpeng Liu2.   

Abstract

As a key signaling molecule, cationic antimicrobial peptide LL37 helps mediate intracellular and extracellular signal transduction. It interacts with various cells facilitating tissue repair and plays a vital role in the defense against pathogens. LL37 acts as a broad-spectrum antimicrobial, possessing antitumor and antiviral properties. It promotes angiogenesis, co-operates with growth factors, antagonizes inflammatory media, participates in immune regulation, and helps tissue repair and growth. These biological effects are closely related to the information exchange between LL37 and various cells, in particular mesenchymal stem cells. Gaining a thorough understanding of the molecular mechanism of communication between LL37 and bone marrow-derived mesenchymal stem cells is crucial. However, work on tissue repair remains at an early stage. This paper reviews the main signal transduction mechanisms operating between LL37 and mesenchymal stem cells in bone and subsequent effects on cell proliferation, migration, and osteogenic differentiation.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  LL37; MSCs; Signal transduction pathway

Mesh:

Year:  2022        PMID: 35048213     DOI: 10.1007/s10735-021-10048-4

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  51 in total

Review 1.  Mesenchymal stromal cells: sensors and switchers of inflammation.

Authors:  Maria Ester Bernardo; Willem E Fibbe
Journal:  Cell Stem Cell       Date:  2013-10-03       Impact factor: 24.633

Review 2.  Compartmentalised MAPK pathways.

Authors:  M D Brown; D B Sacks
Journal:  Handb Exp Pharmacol       Date:  2008

Review 3.  Mesenchymal stem cells and adaptive immune responses.

Authors:  Wei Cao; Kai Cao; Jianchang Cao; Ying Wang; Yufang Shi
Journal:  Immunol Lett       Date:  2015-06-12       Impact factor: 3.685

Review 4.  The MSC curtain that stops the immune system.

Authors:  Arnold I Caplan; J Michael Sorrell
Journal:  Immunol Lett       Date:  2015-06-14       Impact factor: 3.685

Review 5.  The secretome of mesenchymal stromal cells: Role of extracellular vesicles in immunomodulation.

Authors:  Stefania Bruno; Maria Chiara Deregibus; Giovanni Camussi
Journal:  Immunol Lett       Date:  2015-06-15       Impact factor: 3.685

6.  The MSC: an injury drugstore.

Authors:  Arnold I Caplan; Diego Correa
Journal:  Cell Stem Cell       Date:  2011-07-08       Impact factor: 24.633

7.  FPRL-1 Receptor Modulators May Provide Treatment for Inflammation.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2013-05-16       Impact factor: 4.345

Review 8.  LL-37, the only human member of the cathelicidin family of antimicrobial peptides.

Authors:  Ulrich H N Dürr; U S Sudheendra; Ayyalusamy Ramamoorthy
Journal:  Biochim Biophys Acta       Date:  2006-04-04

9.  The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.

Authors:  Seth B Coffelt; Frank C Marini; Keri Watson; Kevin J Zwezdaryk; Jennifer L Dembinski; Heather L LaMarca; Suzanne L Tomchuck; Kerstin Honer zu Bentrup; Elizabeth S Danka; Sarah L Henkle; Aline B Scandurro
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

Review 10.  Performance evaluation of antimicrobial peptide ll-37 and hepcidin and β-defensin-2 secreted by mesenchymal stem cells.

Authors:  Reza Esfandiyari; Raheleh Halabian; Elham Behzadi; Hamid Sedighian; Ramezan Jafari; Abbas Ali Imani Fooladi
Journal:  Heliyon       Date:  2019-10-23
View more
  1 in total

Review 1.  Recent Research on Hybrid Hydrogels for Infection Treatment and Bone Repair.

Authors:  Mengjiao Cao; Chengcheng Liu; Mengxin Li; Xu Zhang; Li Peng; Lijia Liu; Jinfeng Liao; Jing Yang
Journal:  Gels       Date:  2022-05-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.